Latest Breaking News On - Reneo pharmaceuticals inc - Page 1 : comparemela.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, AGR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, AGR
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Daniel sadehZachary halperCrescent energy companyOnkure incPrnewswire halper sadehSilverbow resources incAvangrid incPerficient incEquity fundReneo pharmaceuticals incHalper sadehBow resourcesCrescent energyPre merger reneo

ALERT: Halper Sadeh LLC Continues to Investigate PRFT,

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential.

Zachary halperDaniel sadehCrescent energy companyPerficient incUniti group incSilverbow resources incWindstream holdingsHalper sadehEquity fundReneo pharmaceuticals incOnkure incBow resourcesCrescent energyPre merger reneoElliott investment management

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of

BALA CYNWYD, Pa., May 29, 2024 (GLOBE NEWSWIRE) Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to.

Marc ackermanBrodsky smithOnkure incCrescent energy companyAvangrid incEquity fundReneo pharmaceuticals incSilverbow resources incPerficient incJason brodskyBow resourcesCrescent classSilverbow boardAvangrid boardPre merger reneoReneo board

Reneo Set to Close After Test Failure - Orange County Business Journal

Reneo Pharmaceuticals Inc., which announced in December the failure of its drug to treat rare genetic diseases, said it will be acquired by OnKure Inc., a Boulder, Colo.-based privately held biopharmaceutical company.

San diegoUnited statesOrange countyGregory flesherNicholas saccomanoReneo pharmaceuticals incOnkure therapeutics incOnkure incOnkure therapeuticsExecutive chairman mike greyChief executive gregory flesherBusiness journalAcorn bioventuresCormorant asset managementDeep track capitalPerceptive advisors

Reneo Pharmaceuticals, Inc (NASDAQ:RPHM) Receives Consensus Rating of Reduce from Analysts

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and seven have issued a hold recommendation on the company. The average 1 year target […]

Braden michael leonardCapital managementSecurities exchange commissionReneo pharmaceuticals stock performanceReneo pharmaceuticalsHighbridge capital managementEventide asset managementNews ratings for reneo pharmaceuticals dailyAnalyst recommendations for reneo pharmaceuticalsMarquette asset managementReneo pharmaceuticals incReneo pharmaceuticals company profileGet free reportExchange commissionPoint capitalAsset management